Improving Canadians' lives through client-focused, evidence-based cannabis patient services and products.
Operating in concert, Canada House’s subsidiaries generate world-leading data and shareholder value through the delivery of cannabinoid therapy services (Marijuana For Trauma), evidence-based treatment plans (Knalysis) and products (Abba Medix).
Canada House’s journey began with veterans helping veterans improve their lives with cannabinoid therapy. Through relentless effort and guided by true intent and a patient-focus, we have strategically positioned ourselves within 3 distinct sectors of the industry.
Our Operations at a Glance
Marijuana for Trauma Inc.
Knalysis Technologies Inc.
Abba Medix Corp.
Treating complex health issues through ongoing education, support, and data-driven cannabinoid therapy treatment plans. MFTgroup.ca
Leveraging data generated by Canada House’s operations to improve patient outcomes, optimize productivity and drive profits. Knalysis.com
Producing efficacious cannabis genetics and products to supply Canada House’s growing patient base and known demand. AbbaMedix.com